Robeco Institutional Asset Management B.V. Regeneron Pharmaceuticals, Inc. Transaction History

Robeco Institutional Asset Management B.V.

$51.9 Billion
Q4 2024

A detailed history of Robeco Institutional Asset Management B.V. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 129,308 shares of REGN stock, worth $87.4 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

129,308

Previous 128,178 0.88%

Holding current value

$87.4 Million

Previous $135 Million 31.64%

% of portfolio

0.18%

Previous 0.27%

39 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 22, 2025	BUY	$701.85 - $1046.91 $793,090 - $1.18 Million	1,130 Added 0.88%	129,308 $92.1 Million
Q3 2024 Oct 29, 2024	BUY	$1024.09 - $1201.76 $1.27 Million - $1.49 Million	1,243 Added 0.98%	128,178 $135 Million
Q2 2024 Jul 22, 2024	BUY	$883.2 - $1071.19 $9.33 Million - $11.3 Million	10,568 Added 9.08%	126,935 $133 Million
Q1 2024 Apr 24, 2024	SELL	$902.69 - $993.35 $3.54 Million - $3.9 Million	-3,924 Reduced 3.26%	116,367 $112 Million
Q4 2023 Feb 14, 2024	BUY	$775.18 - $881.7 $43.5 Million - $49.4 Million	56,059 Added 87.28%	120,291 $106 Million
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $39.8 Million - $45.2 Million	-51,301 Reduced 44.4%	64,232 $120 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $5.06 Million - $6.17 Million	-7,312 Reduced 5.95%	115,533 $95.1 Million
Q2 2023 Jul 24, 2023	SELL	$700.03 - $830.35 $404,617 - $479,942	-578 Reduced 0.47%	122,845 $88.3 Million
Q1 2023 May 03, 2023	BUY	$680.49 - $826.97 $255,183 - $310,113	375 Added 0.3%	123,423 $101 Million
Q4 2022 Feb 06, 2023	BUY	$705.89 - $766.39 $13.8 Million - $15 Million	19,598 Added 18.94%	123,048 $88.8 Million
Q3 2022 Dec 01, 2022	BUY	$573.97 - $724.32 $11.9 Million - $15 Million	20,690 Added 25.0%	103,450 $71.3 Million
Q3 2022 Oct 26, 2022	BUY	$573.97 - $724.32 $11.9 Million - $15 Million	20,690 Added 25.0%	103,450 $71.3 Million
Q2 2022 Dec 01, 2022	BUY	$548.35 - $738.84 $8.22 Million - $11.1 Million	14,984 Added 22.11%	82,760 $48.9 Million
Q2 2022 Jul 27, 2022	BUY	$548.35 - $738.84 $8.22 Million - $11.1 Million	14,984 Added 22.11%	82,760 $48.9 Million
Q1 2022 Dec 01, 2022	BUY	$595.12 - $698.43 $10.3 Million - $12.1 Million	17,331 Added 34.36%	67,776 $47.3 Million
Q1 2022 Apr 26, 2022	BUY	$595.12 - $698.43 $10.3 Million - $12.1 Million	17,331 Added 34.36%	67,776 $47.3 Million
Q4 2021 Dec 01, 2022	SELL	$543.48 - $670.97 $4.45 Million - $5.5 Million	-8,193 Reduced 13.97%	50,445 $31.9 Million
Q4 2021 Jan 31, 2022	SELL	$543.48 - $670.97 $4.45 Million - $5.5 Million	-8,193 Reduced 13.97%	50,445 $31.9 Million
Q3 2021 Dec 01, 2022	BUY	$574.03 - $680.96 $12.3 Million - $14.6 Million	21,394 Added 57.44%	58,638 $35.5 Million
Q3 2021 Oct 20, 2021	BUY	$574.03 - $680.96 $12.3 Million - $14.6 Million	21,394 Added 57.44%	58,638 $35.5 Million
Q2 2021 Dec 01, 2022	SELL	$472.8 - $558.54 $35.6 Million - $42.1 Million	-75,370 Reduced 66.93%	37,244 $20.8 Million
Q2 2021 Jul 28, 2021	SELL	$472.8 - $558.54 $35.6 Million - $42.1 Million	-75,370 Reduced 66.93%	37,244 $20.8 Million
Q1 2021 Dec 01, 2022	BUY	$446.73 - $548.2 $4.09 Million - $5.02 Million	9,164 Added 8.86%	112,614 $53.3 Million
Q1 2021 Apr 23, 2021	SELL	$446.73 - $548.2 $20.5 Million - $25.1 Million	-45,859 Reduced 28.94%	112,614 $53.3 Million
Q4 2020 Dec 01, 2022	BUY	$478.3 - $607.98 $26.3 Million - $33.5 Million	55,023 Added 53.19%	158,473 $76.6 Million
Q4 2020 Jan 28, 2021	SELL	$478.3 - $607.98 $7.51 Million - $9.54 Million	-15,697 Reduced 9.01%	158,473 $76.6 Million
Q3 2020 Oct 29, 2020	BUY	$544.75 - $658.21 $10.4 Million - $12.5 Million	19,050 Added 12.28%	174,170 $97.5 Million
Q2 2020 Jul 20, 2020	BUY	$493.32 - $643.92 $59.1 Million - $77.1 Million	119,756 Added 338.64%	155,120 $96.7 Million
Q1 2020 Apr 30, 2020	BUY	$336.18 - $494.43 $7.49 Million - $11 Million	22,290 Added 170.49%	35,364 $17.3 Million
Q4 2019 Feb 06, 2020	SELL	$274.13 - $376.51 $1.4 Million - $1.93 Million	-5,122 Reduced 28.15%	13,074 $4.91 Million
Q3 2019 Oct 17, 2019	SELL	$273.46 - $318.39 $314,479 - $366,148	-1,150 Reduced 5.94%	18,196 $5.05 Million
Q2 2019 Jul 19, 2019	SELL	$299.6 - $414.82 $585,718 - $810,973	-1,955 Reduced 9.18%	19,346 $6.06 Million
Q1 2019 May 02, 2019	BUY	$372.08 - $439.57 $2.95 Million - $3.49 Million	7,931 Added 59.32%	21,301 $8.75 Million
Q4 2018 Feb 08, 2019	BUY	$335.82 - $403.04 $2.62 Million - $3.15 Million	7,806 Added 140.29%	13,370 $4.98 Million
Q3 2018 Oct 25, 2018	BUY	$351.14 - $408.51 $351,140 - $408,510	1,000 Added 21.91%	5,564 $2.25 Million
Q2 2018 Aug 03, 2018	SELL	$284.6 - $344.99 $192,958 - $233,903	-678 Reduced 12.93%	4,564 $1.58 Million
Q1 2018 May 07, 2018	BUY	$315.82 - $393.78 $1.33 Million - $1.66 Million	4,204 Added 405.01%	5,242 $1.81 Million
Q3 2017 Oct 17, 2017	BUY	$431.38 - $504.0 $5,176 - $6,048	12 Added 1.17%	1,038 $463,000
Q1 2017 Jan 19, 2021	BUY	N/A	1,026	1,026 $398,000

Others Institutions Holding REGN

# of Institutions

1,497

Shares Held

82.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account

Robeco Institutional Asset Management B.V. Regeneron Pharmaceuticals, Inc. Transaction History